newsfilter
← Latest News
GlobeNewswire·

Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform

  • BioStem Technologies (NASDAQ: BSEM) has joined the Terminal1 operating system platform.
  • The company will utilize Terminal1's integrated suite for shareholder intelligence, investor communications, and digital investor relations.
  • This move aims to consolidate fragmented investor relations functions into a single centralized system.
  • Terminal1 enables users to analyze shareholder data, manage email and SMS communications, and track IR website analytics.
  • The platform connects shareholder ownership, communications, and digital engagement to provide executives with a complete view of the investor ecosystem.
  • BioStem Technologies is a biomedical innovator focused on developing allograft solutions derived from perinatal tissue.
  • Terminal1 continues to expand its public-company customer base while building out additional capabilities across shareholder intelligence & analytics.